Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA, a Randomized Controlled Trial

NCT06591351 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT06591351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06591351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA, a Randomized Controlled Trial
Lead sponsor
Kafrelsheikh University
Phase
Phase 3
Overall status
Recruiting
Start date
May 1, 2022
Completion date
October 10, 2024
Enrollment
870 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke